Global Polio (Poliomyelitis) Vaccines Market Research Report 2021

1 Polio (Poliomyelitis) Vaccines Market Overview

• 1.1 Product Overview and Scope of Polio (Poliomyelitis) Vaccines
• 1.2 Polio (Poliomyelitis) Vaccines Segment by Type
  • 1.2.1 Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate Analysis by Type 2021 VS 2027
  • 1.2.2 Inactivated Polio Vaccine (IPV)
  • 1.2.3 Oral Polio Vaccine (OPV)
• 1.3 Polio (Poliomyelitis) Vaccines Segment by Application
  • 1.3.1 Global Polio (Poliomyelitis) Vaccines Consumption Comparison by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Research & Academic Laboratories
  • 1.3.3 Pharmaceutical & Biotechnology Companies
  • 1.3.4 Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Polio (Poliomyelitis) Vaccines Revenue Estimates and Forecasts (2016-2027)
  • 1.4.2 Global Polio (Poliomyelitis) Vaccines Production Capacity Estimates and Forecasts (2016-2027)
  • 1.4.3 Global Polio (Poliomyelitis) Vaccines Production Estimates and Forecasts (2016-2027)
• 1.5 Global Polio (Poliomyelitis) Vaccines Market by Region
  • 1.5.1 Global Polio (Poliomyelitis) Vaccines Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
  • 1.5.2 North America Polio (Poliomyelitis) Vaccines Estimates and Forecasts (2016-2027)
  • 1.5.3 Europe Polio (Poliomyelitis) Vaccines Estimates and Forecasts (2016-2027)
  • 1.5.5 China Polio (Poliomyelitis) Vaccines Estimates and Forecasts (2016-2027)
  • 1.5.5 Japan Polio (Poliomyelitis) Vaccines Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

• 2.1 Global Polio (Poliomyelitis) Vaccines Production Capacity Market Share by Manufacturers (2016-2021)
• 2.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Polio (Poliomyelitis) Vaccines Average Price by Manufacturers (2016-2021)
• 2.5 Manufacturers Polio (Poliomyelitis) Vaccines Production Sites, Area Served, Product Types
• 2.6 Polio (Poliomyelitis) Vaccines Market Competitive Situation and Trends
  • 2.6.1 Polio (Poliomyelitis) Vaccines Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Polio (Poliomyelitis) Vaccines Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

• 3.1 Global Production Capacity of Polio (Poliomyelitis) Vaccines Market Share by Region (2016-2021)
• 3.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2016-2021)
• 3.3 Global Polio (Poliomyelitis) Vaccines Production, Revenue, Price and Gross Margin (2016-2021)
• 3.4 North America Polio (Poliomyelitis) Vaccines Production
  • 3.4.1 North America Polio (Poliomyelitis) Vaccines Production Growth Rate (2016-2021)
  • 3.4.2 North America Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.5 Europe Polio (Poliomyelitis) Vaccines Production
  • 3.5.1 Europe Polio (Poliomyelitis) Vaccines Production Growth Rate (2016-2021)
  • 3.5.2 Europe Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.6 China Polio (Poliomyelitis) Vaccines Production
  • 3.6.1 China Polio (Poliomyelitis) Vaccines Production Growth Rate (2016-2021)
  • 3.6.2 China Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.7 Japan Polio (Poliomyelitis) Vaccines Production
  • 3.7.1 Japan Polio (Poliomyelitis) Vaccines Production Growth Rate (2016-2021)
  • 3.7.2 Japan Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Polio (Poliomyelitis) Vaccines Consumption by Region

• 4.1 Global Polio (Poliomyelitis) Vaccines Consumption by Region
  • 4.1.1 Global Polio (Poliomyelitis) Vaccines Consumption by Region
  • 4.1.2 Global Polio (Poliomyelitis) Vaccines Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Polio (Poliomyelitis) Vaccines Consumption by Country
  • 4.2.2 U.S.
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Polio (Poliomyelitis) Vaccines Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Polio (Poliomyelitis) Vaccines Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Polio (Poliomyelitis) Vaccines Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

• 5.1 Global Polio (Poliomyelitis) Vaccines Production Market Share by Type (2016-2021)
• 5.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2016-2021)
• 5.3 Global Polio (Poliomyelitis) Vaccines Price by Type (2016-2021)

6 Consumption Analysis by Application

• 6.1 Global Polio (Poliomyelitis) Vaccines Consumption Market Share by Application (2016-2021)
• 6.2 Global Polio (Poliomyelitis) Vaccines Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

• 7.1 Sanofi
  • 7.1.1 Sanofi Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.1.2 Sanofi Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.1.3 Sanofi Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.1.4 Sanofi Main Business and Markets Served
  • 7.1.5 Sanofi Recent Developments/Updates
• 7.2 GSK
  • 7.2.1 GSK Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.2.2 GSK Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.2.3 GSK Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.2.4 GSK Main Business and Markets Served
  • 7.2.5 GSK Recent Developments/Updates
• 7.3 Bibcol
  • 7.3.1 Bibcol Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.3.2 Bibcol Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.3.3 Bibcol Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.3.4 Bibcol Main Business and Markets Served
  • 7.3.5 Bibcol Recent Developments/Updates
• 7.4 Serum Institute
  • 7.4.1 Serum Institute Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.4.2 Serum Institute Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.4.4 Serum Institute Main Business and Markets Served
  • 7.4.5 Serum Institute Recent Developments/Updates
• 7.5 Tiantan Biological
  • 7.5.1 Tiantan Biological Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.5.2 Tiantan Biological Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.5.4 Tiantan Biological Main Business and Markets Served
  • 7.5.5 Tiantan Biological Recent Developments/Updates
• 7.6 IMBCA
  • 7.6.1 IMBCA Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.6.2 IMBCA Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.6.3 IMBCA Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.6.4 IMBCA Main Business and Markets Served
  • 7.6.5 IMBCA Recent Developments/Updates
• 7.7 Panacea Biotec Ltd
  • 7.7.1 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.7.2 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.7.4 Panacea Biotec Ltd Main Business and Markets Served
  • 7.7.5 Panacea Biotec Ltd Recent Developments/Updates
• 7.8 Bio-Med
  • 7.8.1 Bio-Med Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.8.2 Bio-Med Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.8.4 Bio-Med Main Business and Markets Served
  • 7.7.5 Bio-Med Recent Developments/Updates
• 7.9 Halfkin Bio-Pharmaceuticals
  • 7.9.1 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Corporation Information
  • 7.9.2 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Portfolio
  • 7.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.9.4 Halfkin Bio-Pharmaceuticals Main Business and Markets Served
  • 7.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

8 Polio (Poliomyelitis) Vaccines Manufacturing Cost Analysis

• 8.1 Polio (Poliomyelitis) Vaccines Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Raw Materials Price Trend
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Polio (Poliomyelitis) Vaccines
• 8.4 Polio (Poliomyelitis) Vaccines Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Polio (Poliomyelitis) Vaccines Distributors List
• 9.3 Polio (Poliomyelitis) Vaccines Customers

10 Market Dynamics

• 10.1 Polio (Poliomyelitis) Vaccines Industry Trends
• 10.2 Polio (Poliomyelitis) Vaccines Growth Drivers
• 10.3 Polio (Poliomyelitis) Vaccines Market Challenges
• 10.4 Polio (Poliomyelitis) Vaccines Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Polio (Poliomyelitis) Vaccines by Region (2022-2027)
• 11.2 North America Polio (Poliomyelitis) Vaccines Production, Revenue Forecast (2022-2027)
• 11.3 Europe Polio (Poliomyelitis) Vaccines Production, Revenue Forecast (2022-2027)
• 11.4 China Polio (Poliomyelitis) Vaccines Production, Revenue Forecast (2022-2027)
• 11.5 Japan Polio (Poliomyelitis) Vaccines Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Polio (Poliomyelitis) Vaccines
• 12.2 North America Forecasted Consumption of Polio (Poliomyelitis) Vaccines by Country
• 12.3 Europe Market Forecasted Consumption of Polio (Poliomyelitis) Vaccines by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Polio (Poliomyelitis) Vaccines by Region
• 12.5 Latin America Forecasted Consumption of Polio (Poliomyelitis) Vaccines by Country

13 Forecast by Type and by Application (2022-2027)

• 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
  • 13.1.1 Global Forecasted Production of Polio (Poliomyelitis) Vaccines by Type (2022-2027)
  • 13.1.2 Global Forecasted Revenue of Polio (Poliomyelitis) Vaccines by Type (2022-2027)
  • 13.1.3 Global Forecasted Price of Polio (Poliomyelitis) Vaccines by Type (2022-2027)
• 13.2 Global Forecasted Consumption of Polio (Poliomyelitis) Vaccines by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List